Clinical Trial Update: Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating hyalurnic acid levels in β-thalassemic children treated for hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Hepatitis C

Snippet

Sponsor: Tanta University | Conditions: Beta-Thalassemia, Hepatitis C | Phase 4 | Status: COMPLETED